ImmunologybioRxiv
Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates
S. Pillet, P. S. Arunachalam, G. Andreani…·N. Landry
This study evaluates the safety and immunogenicity of a plant-derived VLP vaccine against SARS-CoV-2 in non-human primates, finding that AS03 adjuvanted vaccine provides better protection and immune response.
DOI 10.1038/s41423-021-00809-2